|
Black HR, Elliott WJ, Neaton JD, Grandits G, Grambsch
P, Grimm Jr RH, et al. Baseline characteristics
and early blood pressure control in the CONVINCE trial. Hypertension.
2001;37(1):12-18.
Blank RD, Margolis KL, Ensrud KE. Body
size and vertebral fractures. Ann Intern Med. 2001;134(9 I):795-796.
Grandits GA, Grimm RH Jr, Prineas RJ,
Grambsch P, Holland LA. Obtaining event status at the close of the Treatment
of Mild Hypertension Study: methods and implication for other trials.
Control Clin Trials. 2001;22(1):56-61.
Grimm RH Jr, Margolis KL, Papademetriou
V, et al. Baseline characteristics of participants in the Antihypertensive
and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Hypertension.
2001;37(1):19-27.
Grimm RH Jr, Prineas RJ, Roel
J, Grandits G. The treatment of mild hypertension study (TOMHS):
design and additional analyses. In: Black H, ed. Clinical Trials in Hypertension.
New York: Marcell Dekker; 2001:253-281.
Hernandez D, Hanson E, Kasiske MK, Danielson B, Roel
J, Kasiske BL. Cytomegalovirus disease is not a major risk factor
for ischemic heart disease after renal transplantation. Transplantation.
2001;72(8):1395-1399. (Also listed under Nephrology)
Kasiske BL, Andany MA, Hernandez D,
Silkensen J, Rabb H, McClean J, Roel
JP, Danielson B. Comparing methods for monitoring serum creatinine
to predict late renal allograft failure. Am J Kidney Dis. 2001;38(5):1065-1073.
(Also listed under Nephrology)
Roel JP, Grimm
RH Jr. Suspect hypertension in patients with erectile dysfunction.
Med Aspects Hum Sex. 2001;1(3):33-39.
Roel JP, Hildebrant CL, Grimm
RH Jr. Quality of life with nonpharmocologic treatment of hypertension.
Curr Hypertens Rep. 2001;3(6):466-472.
|
